A clinical trial is a study where doctors test new treatments, like medicines or procedures, on people. These studies help doctors learn if a new treatment works and is safe. Researchers carefully choose participants and follow them to see how the treatment affects them. It's a way to find out if new medical approaches are effective.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
A clinical trial is a research study that tests a new medical approach in people, such as a medicine, device, surgery, screening test or behavioral therapy. A controlled trial compares a group receiving the approach being studied with a control group receiving standard treatment or, in some trials, a placebo. That comparison shows whether the new approach adds anything beyond usual care. Each trial has eligibility criteria, such as age, the condition and its stage, past treatment and other health problems. Some studies need people with the condition; others need healthy volunteers, whose studies are designed to build knowledge rather than to benefit them. People join to help answer a medical question or to reach a treatment not yet widely available. Standard care outside a trial remains the usual alternative.
Joining usually starts with screening, in which the study team reviews medical history and may run tests to confirm eligibility. Informed consent follows: the team explains the study's purpose, visits, procedures, risks and possible benefits, and provides a written form to read and ask about. The form is not a contract. Taking part is voluntary, and a participant can leave at any time without losing regular medical care. It is worth asking whether an Institutional Review Board (IRB), an independent committee that protects research participants, reviewed the study; most US trials have one. Ask too which costs are covered. The sponsor often pays for the study drug and research-only tests, insurance usually covers routine care, and travel, lodging or childcare may fall to the participant.
Some trials need only a few visits; others add hospital stays, extra blood tests and procedures, or complex dosing schedules. In a randomized trial, a computer assigns people to groups by chance, which keeps the groups comparable; neither the participant nor their doctor can choose. A placebo is an inactive product made to look like the real one. People are told before joining if a trial uses one, and placebos are not used when going without effective treatment would put people at risk. In a blinded trial, the participant does not know which treatment they receive; in a double-blind trial, the research team does not know either. This keeps expectations from coloring the results, and the assignment can be found out if medically necessary.
Participation ends when the study finishes, when a person decides to leave, or when the team decides stopping is in their best interest. Some study treatments need to be stopped gradually or followed by safety checks, so tell the study team before stopping anything. Afterward, people can ask about the results and, in many blinded trials, which treatment they received. During the study, report side effects or new symptoms to the study team using the contacts on the consent form. In an emergency, get emergency medical help immediately, then let the study team know.
The central trade-off is uncertainty. A study treatment may not work as well as standard treatment, and its side effects may be worse. Most trials bring only minor, short-lived discomfort, but some participants have complications needing medical attention, and rarely experimental treatments have caused serious or life-threatening harm. A new treatment can also carry risks no one yet knows about, including to a pregnancy, and some participants get no direct benefit. A separate risk comes from outside legitimate research. Some clinics advertise unproven, unapproved treatments, such as stem cell or exosome products, as clinical trials and charge thousands of dollars. Before receiving an unapproved drug or cell product, the US Food and Drug Administration (FDA) suggests asking for its FDA-issued Investigational New Drug (IND) number and confirming it with your own clinician.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Clinical Trial, what to expect, or ask the community a question.